Open access · US-GOV via ClinicalTrials.gov Clinical trial

An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Intra-venous Implantation of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome

Authors not listed

Ageless Regenerative Institute · 2011

Stem-cell exhaustion Human Randomized controlled trial

Abstract

The intent of this clinical study is to answer the questions: 1. Is the proposed treatment safe 2. Is treatment effective in improving the health of patients with human frailty syndrome.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-15 MST

Cite this

APA

Anonymous. (2011). An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Intra-venous Implantation of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome. <em>Ageless Regenerative Institute</em>. https://clinicaltrials.gov/study/NCT01501461

Vancouver

Anonymous. An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Intra-venous Implantation of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome. Ageless Regenerative Institute. 2011.

BibTeX

@misc{anon2011AnOpen, title = {An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Intra-venous Implantation of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome}, author = {Anonymous}, journal = {Ageless Regenerative Institute}, year = {2011}, }